Total Funding
55
Total FundingSeries B raised
Growth Score
pts
Heat Score
12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
659793
Hypnion is a neuroscience drug discovery company.
About the Company
Hypnion is a neuroscience drug discovery and development company that develops novel therapeutics for the treatment of central nervous system disorders. The company develops treatments for sleep- and wake-alertness disorders and circadian rhythm abnormalities.
Hypnion offers SCORE-2004, a drug discovery platform that is able to measure drugs’
impact on sleep and wake parameters.
Hypnion is acquired by Eli Lilly and Company.
Hypnion was founded in 2000 and is based in Worcester, Massachusetts.
